Helene Drouin: my commitment in supporting medical research
Against liver cancer: Hepatitis B research
I’m doing a fund-raising campaign with companies to support medical research against liver cancer with Professor Fabien Zoulim, a worldwide renowned specialist in the field. Prof. Zoulim is an expert on Hepatitis B, the first cause of liver cancer. He has just founded the Institute of Hepatology of Lyon in France.
Hepatitis B has been declared by the World Health Organisation (WHO) as a major public health issue. Despite an efficient vaccine, there are still over 250 million chronic carriers of the virus and over 900,000 deaths each year.
Recently discovered short-term therapies could completely cure the infection. Such results would improve the quality of life of patients, save millions of lives lost to liver cancer and reduce the economic burden of lifelong treatment.
With generous support from corporations like yours, we can accelerate research in this field, and combined with a better vaccination coverage, we can hope to cure hepatitis B within a decade!
Professor Fabien Zoulim: a renowned HBV expert
Since 2020, Prof. Zoulim is Chair of the International Coalition to Eliminate HBV, ICE-HBV, an organization which is supported by the World Health Organization (WHO).
He has just founded the new Institute of Hepatology of Lyon in France, first and unique hospital specialized in liver diseases.
Prof. Zoulim is Professor of Medicine at Lyon University, France, Head of the Hepatology Department , Head of the Viral Hepatitis research laboratory at INSERM U1052 and Head of the ANRS "HBV Cure" Task Force in France.
Our project is supported by research institutions: ANRS INSERM ICE-HBV
- Liver cancer: 3rd deadliest cancer in the world
- Main causes: hepatitis B and C, alcoholism
- Hepatitis B: 250 million chronically infected patients in the world
- Hepatitis B provokes 900 000 deaths each year